Aspirin to Prevent Preeclampsia in Women With Elevated Blood Pressure and Stage 1 Hypertension (ASPPIRE)
Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
To determine if low dose aspirin reduces the incidence of hypertensive disorders of pregnancy
(gestational hypertension, preeclampsia, eclampsia, and HELLP syndrome) in pregnant women
with stage 1 hypertension and elevated blood pressure.